Induction of diabetes in NOD<->C57BL/6 embryo aggregation chimeras by cyclophosphamide through preferential depletion of C57BL/6 lymphocytes

Journal of Autoimmunity

Volumn 9, Issue 4, 1996, Pages 493-499

  Colucci, Francesco ^a   Lejon, Kristina ^a   Cilio, Corrado M ^a,b   Bergqvist, Ingela ^a   Matsunaga, Takeshi ^a   Holmberg, Dan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

IDDM; Immunoregulation; NOD mouse; Organ specific autoimmunity

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CHIMERA; CONTROLLED STUDY; ETIOLOGY; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030218108     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0066     Document Type: Article

References (35)

1. 1. Castano L., Eisenbarth G.S. 1990. Type 1 diabetes. Chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8: 647-679
2. 2. Miyazaki A., Hanafusa T., Yamada K., Miyagawa J., Nakajima H., Nonaka K., Tami S. 1985. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol. 6: 622-625
3. 3. Shizuru J.A., Taylor-Edwards C., Banks B.A., Gregory A.K., Fathman G.C. 1988. Immunotherapy of the non-obese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240: 659-662
4. 4. Bendelac A., Carnaud C., Boitard C., Bach J.-F. 1987. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates, requirements for both L3T4-and Lyt-2-T cells. J. Exp. Med. 166: 823-832
5. 5. Miller B.J., Appel M.C., O'Neil J.J., Wicker L.S. 1988. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J. Immunol. 140: 52-58
6. 6. Ghosh S., Palmer S.M., Rodrigues N.R., Cordell H.J., Hearne C.M., Cornall R.J., Prins J.-B., McShane P., Lathrop G.M., Peterson L.B., Wicker L.S., Todd J.A. 1993. Polygenetic control of autoimmune diabetes in nonobese diabetic mice. Nature Genetics 4: 404-409
7. 7. Wicker L.S., Todd J.A., Peterson L.B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol 13: 179-200
8. 8. Hattori M., Buse J.B., Jacobson R.A., Glimcher L., Dorf M.E., Minami M., Makino S., Moriwaki K., Kuzuya H., Imura H., Strauss W.M., Seidman J.D., Eisenbarth G.S. 1986. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231: 733-735
9. 9. Wicker L.S., Miller B.J., Coker L.Z., McNally S.E., Scott S., Mullen Y., Appel M.C. 1987. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J. Exp. Med. 165: 1639-1654
10. 10. Acha-Orbea H., McDevitt H.O. 1987. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc. Natl. Acad. Sci. USA 84: 2435-2439
11. 11. Katz J., Benoist C., Mathis D. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23: 3358-3360
12. 12. Wicker L.S., Leiter E.H., Todd J.A. 1994. B2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500-504
13. null mice are diabetes and insulitis resistant. Diabetes 43: 505-509
14. 14. Miyazaki T., Matsuda Y., Yoyonaga T., Miyazaki J., Yazaky Y., Yamamura K. 1992. Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecule. Proc. Natl. Acad. Sci. USA 89: 9519-9523
15. 15. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. 1987. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432-434
16. k transgenic mice. Nature 345: 724-726
17. 17. Lund T., O'Reilly L., Hutchings P., Kanagawa O., Simpson E., Gravely R., Chandler P., Dyson J., Picard J.K., Edwards A., Kioussis D., Cooke A. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345: 727-729
18. 18. Bach, M.-F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 15: 516-542
19. 19. Deng H., Apple R., Clare-Salzler M., Trembleau S., Mathis D., Adorini L., Sercarz E. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178: 1675-1680
20. 20. Hutchings P.R., Cooke A. 1990. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun. 3: 175-185
21. 21. Dardenne M., Lepault F., Bendelac A., Bach J.-F. 1989. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19: 889-895
22. 22. Harada M., Makino S. 1984. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27: 604-606
23. 23. Yasunami R., Bach J.-F. 1988. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18: 481-484
24. 24. Charlton B., Bacelj A., Slattery R.M., Mandel T.E. 1989. Cyclophosphamide-induced diabetes in NOD/WeHi mice: evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 38: 441-447
25. 25. Bach J.-F., Boitard C., Yasunami R., Dardenne M. 1990. Control of diabetes in NOD mice by suppressor cells. J. Autoimmun. 3 (Suppl.): 97-100
26. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90: 9566-9570
27. 27. McLaren A. 1976. Mammalian Chimeras. Cambridge Univ. Press, Cambridge, UK, pp. 1-9
28. 28. Forsgren S., Dahl U., Söderström Å, Holmberg D., Matsunaga T. 1991. The phenotype of lymphoid cells and thymic epithelium correlates with development of autoimmune insulitis in NOD-C57BL/6 allophenic chimeras. Proc. Natl. Acad. Sci. USA 88: 9335-9339
29. 29. Leijon K., Holmberg D. 1995. Specific destruction of islet transplants in NOD<->C57BL/6 and NOD<->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in β-cell antigens. J. Autoimmun. 8: 347-356
30. 30. Shinkai Y., Rathbun G., Lam K.-P., Oltz E., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A., Alt F. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangements. Cell 68: 855-867
31. 31. Hogan B., Constantini F., Lacy E. 1986. Manipulating the Mouse Embryo, A Laboratory Manual. Cold Spring Harbor Laboratory, New York, pp. 249-257
32. 32. Ozato K., Sachs D.H. 1981. Monoclonal antibodies to mouse MHC antigens. J. Immunol. 126: 317-321
33. 33. Boitard C., Bendelac A., Dardenne M., Bach J.-F. 1989. T-cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169: 1669-1680
34. 34. Wicker L.S., Miller B., Chai A., Terada M., Mullen Y. 1988. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD×B10)F1 mice with bone marrow cells from NOD mice. J. Exp. Med. 167: 1801-1810
35. 35. Sampe P., Richard M.F., Bach J.-F., Boitard C. 1994. Evidence of CD4+ regulatory T cells in the nonobese diabetic male mouse. Diabetologia 37: 337-343